Graham Capital Management L.P. Invests $463,000 in Pediatrix Medical Group, Inc. (NYSE:MD)

Graham Capital Management L.P. purchased a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 35,299 shares of the company's stock, valued at approximately $463,000.

A number of other large investors have also made changes to their positions in MD. Franklin Resources Inc. acquired a new position in shares of Pediatrix Medical Group in the third quarter valued at approximately $598,000. Ritholtz Wealth Management acquired a new stake in shares of Pediatrix Medical Group during the fourth quarter worth $182,000. SG Americas Securities LLC bought a new stake in Pediatrix Medical Group in the 4th quarter valued at $171,000. Pacer Advisors Inc. acquired a new position in Pediatrix Medical Group in the 4th quarter worth $35,492,000. Finally, Empowered Funds LLC raised its stake in shares of Pediatrix Medical Group by 5.1% in the 4th quarter. Empowered Funds LLC now owns 280,445 shares of the company's stock valued at $3,679,000 after purchasing an additional 13,607 shares during the period. Institutional investors own 97.71% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on MD. Macquarie lifted their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Truist Financial dropped their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. UBS Group decreased their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 12th. Finally, StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Trading Up 1.0%

Shares of MD stock traded up $0.16 during trading hours on Wednesday, hitting $15.32. 244,441 shares of the company's stock traded hands, compared to its average volume of 849,068. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The stock has a market cap of $1.32 billion, a PE ratio of -12.74, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The stock's 50 day simple moving average is $13.75 and its 200 day simple moving average is $14.12.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. During the same period in the previous year, the business earned $0.20 EPS. The business's quarterly revenue was down 7.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.